Institutional investors purchased a net $765.7 thousand shares of ADXS during the quarter ended January 2017. This may signal that the smart money is gaining interest in this company as the 56.71% of shares outstanding that institutional investors hold is actually below the Biotechnology industry average.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
MARSHALL WACE NORTH AMERICA LP Bought 306.8 Thousand shares of Advaxis Inc
FIDELITY MANAGEMENT & RESEARCH C... Bought 168.9 Thousand shares of Advaxis Inc
SECTORAL ASSET MANAGEMENT, INC. Bought 149.7 Thousand shares of Advaxis Inc